nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Localized exfoliation—Bleomycin—lymphatic system cancer	0.0769	0.0769	CcSEcCtD
Vildagliptin—Blister—Mechlorethamine—lymphatic system cancer	0.0605	0.0605	CcSEcCtD
Vildagliptin—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.0331	0.0331	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0267	0.0267	CcSEcCtD
Vildagliptin—Liver function test abnormal—Teniposide—lymphatic system cancer	0.0215	0.0215	CcSEcCtD
Vildagliptin—Skin exfoliation—Bleomycin—lymphatic system cancer	0.0198	0.0198	CcSEcCtD
Vildagliptin—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.0189	0.0189	CcSEcCtD
Vildagliptin—Skin exfoliation—Carmustine—lymphatic system cancer	0.0173	0.0173	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.0165	0.0165	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0161	0.0161	CcSEcCtD
Vildagliptin—Infection—Mechlorethamine—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Vildagliptin—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Vildagliptin—Chills—Teniposide—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Vildagliptin—Chills—Fludarabine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Vildagliptin—Malnutrition—Fludarabine—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Vildagliptin—Liver function test abnormal—Carmustine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Vildagliptin—Oedema—Teniposide—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Vildagliptin—Infection—Teniposide—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Vildagliptin—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Vildagliptin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Vildagliptin—Arthralgia—Fludarabine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Vildagliptin—Oedema—Fludarabine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Vildagliptin—Infection—Fludarabine—lymphatic system cancer	0.01	0.01	CcSEcCtD
Vildagliptin—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00989	0.00989	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.0098	0.0098	CcSEcCtD
Vildagliptin—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00975	0.00975	CcSEcCtD
Vildagliptin—Weight increased—Mitoxantrone—lymphatic system cancer	0.0096	0.0096	CcSEcCtD
Vildagliptin—Chills—Bleomycin—lymphatic system cancer	0.00934	0.00934	CcSEcCtD
Vildagliptin—Nausea—Mechlorethamine—lymphatic system cancer	0.00924	0.00924	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00919	0.00919	CcSEcCtD
Vildagliptin—Urticaria—Teniposide—lymphatic system cancer	0.00911	0.00911	CcSEcCtD
Vildagliptin—Oedema peripheral—Carmustine—lymphatic system cancer	0.00895	0.00895	CcSEcCtD
Vildagliptin—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00893	0.00893	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0087	0.0087	CcSEcCtD
Vildagliptin—Fatigue—Fludarabine—lymphatic system cancer	0.00869	0.00869	CcSEcCtD
Vildagliptin—Constipation—Fludarabine—lymphatic system cancer	0.00862	0.00862	CcSEcCtD
Vildagliptin—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00852	0.00852	CcSEcCtD
Vildagliptin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00844	0.00844	CcSEcCtD
Vildagliptin—Asthenia—Teniposide—lymphatic system cancer	0.00823	0.00823	CcSEcCtD
Vildagliptin—Skin exfoliation—Methotrexate—lymphatic system cancer	0.008	0.008	CcSEcCtD
Vildagliptin—Malnutrition—Carmustine—lymphatic system cancer	0.00791	0.00791	CcSEcCtD
Vildagliptin—Angiopathy—Vincristine—lymphatic system cancer	0.00787	0.00787	CcSEcCtD
Vildagliptin—Diarrhoea—Teniposide—lymphatic system cancer	0.00785	0.00785	CcSEcCtD
Vildagliptin—Chills—Mitoxantrone—lymphatic system cancer	0.00758	0.00758	CcSEcCtD
Vildagliptin—Tremor—Carmustine—lymphatic system cancer	0.00741	0.00741	CcSEcCtD
Vildagliptin—Oedema—Bleomycin—lymphatic system cancer	0.00739	0.00739	CcSEcCtD
Vildagliptin—Infection—Bleomycin—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Vildagliptin—Asthenia—Fludarabine—lymphatic system cancer	0.00723	0.00723	CcSEcCtD
Vildagliptin—Headache—Teniposide—lymphatic system cancer	0.00719	0.00719	CcSEcCtD
Vildagliptin—Diarrhoea—Fludarabine—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Vildagliptin—Nausea—Teniposide—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Vildagliptin—Oedema—Carmustine—lymphatic system cancer	0.00645	0.00645	CcSEcCtD
Vildagliptin—Infection—Carmustine—lymphatic system cancer	0.00641	0.00641	CcSEcCtD
Vildagliptin—Headache—Fludarabine—lymphatic system cancer	0.00632	0.00632	CcSEcCtD
Vildagliptin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00626	0.00626	CcSEcCtD
Vildagliptin—Oedema—Vincristine—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Vildagliptin—Infection—Vincristine—lymphatic system cancer	0.00612	0.00612	CcSEcCtD
Vildagliptin—Nervous system disorder—Vincristine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Vildagliptin—Oedema—Mitoxantrone—lymphatic system cancer	0.006	0.006	CcSEcCtD
Vildagliptin—Nausea—Fludarabine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Vildagliptin—Infection—Mitoxantrone—lymphatic system cancer	0.00596	0.00596	CcSEcCtD
Vildagliptin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00595	0.00595	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00588	0.00588	CcSEcCtD
Vildagliptin—Urticaria—Bleomycin—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Vildagliptin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00583	0.00583	CcSEcCtD
Vildagliptin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.0058	0.0058	CcSEcCtD
Vildagliptin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Vildagliptin—Constipation—Carmustine—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00547	0.00547	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Vildagliptin—Fatigue—Vincristine—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Vildagliptin—Asthenia—Bleomycin—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Vildagliptin—Constipation—Vincristine—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Vildagliptin—Fatigue—Mitoxantrone—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Vildagliptin—Pancreatitis—Methotrexate—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Vildagliptin—Constipation—Mitoxantrone—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Vildagliptin—Urticaria—Mitoxantrone—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Vildagliptin—Infestation NOS—Methotrexate—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Vildagliptin—Infestation—Methotrexate—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Vildagliptin—Asthenia—Carmustine—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Vildagliptin—Asthenia—Vincristine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Vildagliptin—Diarrhoea—Carmustine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Vildagliptin—Nausea—Bleomycin—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Vildagliptin—Asthenia—Mitoxantrone—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Vildagliptin—Dizziness—Carmustine—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Vildagliptin—Diarrhoea—Vincristine—lymphatic system cancer	0.00421	0.00421	CcSEcCtD
Vildagliptin—Hepatitis—Methotrexate—lymphatic system cancer	0.00421	0.00421	CcSEcCtD
Vildagliptin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Vildagliptin—Dizziness—Vincristine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Vildagliptin—Headache—Carmustine—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Vildagliptin—Headache—Vincristine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Vildagliptin—Nausea—Carmustine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Vildagliptin—Angiopathy—Methotrexate—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Vildagliptin—Chills—Methotrexate—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Vildagliptin—Headache—Mitoxantrone—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Vildagliptin—Malnutrition—Methotrexate—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Vildagliptin—Nausea—Vincristine—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Vildagliptin—Nausea—Mitoxantrone—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Vildagliptin—Arthralgia—Methotrexate—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Vildagliptin—Infection—Methotrexate—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Vildagliptin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Vildagliptin—Skin disorder—Methotrexate—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Vildagliptin—Fatigue—Methotrexate—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Vildagliptin—Urticaria—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Vildagliptin—Asthenia—Methotrexate—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Vildagliptin—Diarrhoea—Methotrexate—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Vildagliptin—Dizziness—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Vildagliptin—Headache—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Vildagliptin—Nausea—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
